Particulate matter in injections according to USP <788> and Ph. Eur. 2.9.19

Quantification of subvisible particulate matter in injectable and parenteral solutions according to USP <788> or the harmonized method Ph. Eur. 2.9.19. Testing is commonly performed as part of batch release and compliance verification against particle count limits.

We offer both methods specified in USP <788> and Ph. Eur. 2.9.19:

  • Method 1: Light obscuration particle count

  • Method 2: Microscopic particle count

Method 1 is generally preferred unless the sample is not suited to it, for example, because of high viscosity, opacity, or a tendency to form gas bubbles. In some cases, it may be necessary to perform both tests (e.g., when Method 1 results are borderline).

Results are reported as particle counts by size range per container or per specified sampling unit. A comparison against the applicable pharmacopoeial limits or customer-defined specifications is also provided.

Suitable sample matrices
Parenteral pharmaceutical products intended for intramuscular, subcutaneous, or intravenous administration; sterilized water for injections
Required sample quantity
3-5 pieces/material
Typical turnaround time
5 – 6 weeks after receiving the samples
Available quality systems
Accredited testing laboratory, GMP test method
Standard
Questions? We're happy to help.
Questions? We're happy to help.
Ringing phone
Kone logoNeste logoFermion logoPlanmeca logoSulapac logoOkmetic logo

Ask for an offer

Fill in the form, and we'll reply in one business day.

Have questions or need help? Email us at or call our sales team.